Chronic discoid lupus erythematosus (CDLE)

Last Updated: 2022-03-11

Author(s): Anzengruber F., Navarini A.

ICD11: EB51.0

Cazenave (Paris), 1844

Integumentary lupus erythematosus, lupus erythematosus chronicus discoides, lupus erythematosus chronicus, discoid lupus erythematosus (DLE), discoid lupus erythematosus.

Chronic cutaneous form of lupus erythematodes (LE).

  • Most common cutaneous form of LE
  • First manifestation is usually between 20-40 yrs
  • Females are more commonly affected: 2:1-4:1
  • More common in dark-skinned individuals

  • Division
    • Localised form (approx. 80 %): head
    • Disseminated form (approx. 20 %): head, trunk and extensor sides of extremities
    • DLE of the oral mucosa: especially buccal mucosa is affected, less frequently the palate
  • Genetics almost certainly play a role
  • Trigger factors
    • Cold.
    • UV radiation (triggering reproducible in 30-40% of patients by light (UVB))
      • Tanning beds can also trigger an exacerbation, and in rare cases lupus nephritis

  • Discoid, sharply demarcated, erythematous plaques with partial follicular hyperkeratosis. Some patients report hyperaesthesia in the area of the skin lesions. Dolent "tape nail phenomenon". The skin lesions heal leaving atrophic skin
  • There are few plaques, some occurring solitarily
  • Pigmentary shifts (hypo/hyperpigmentation), telangiectasias note in the centre of the foci
  • The palpation is coarse/hardened, on the other hand hardly raised above the surrounding skin surface
  • Healing at the capillitium may occur in the setting of scarring alopecia. Scarring periorale, in the nasal and oral mucosa

  • Clinical findings
  • Biopsy with direct immunofluorescence
  • Autoantibodies are mostly negative
    • ANA (5% ↑), usually.
    • Anti-dsDNA (rare).
    • Ro/SSA (rare).
    • U1-RNP (rare).

UV-exposed areas.

Moderate compact ortho- and parahyperkeratosis, follicular hyperkeratosis, acanthosis or atrophy of the epidermis, hydropic degeneration of the cells of the stratum basale, necrotic/apoptotic keratinocytes in the basal epidermis (colloid bodies), oedema in the upper corium, interfaced dermatitis, widened PAS-positive basement membrane, periadnexal and perivascular lymphocytic infiltrates.

Direct immunofluorescence: In affected, but not in unaffected skin, a positive lupus band test with IgG, IgM, IgA, C1 and C3 is found.

The disseminated form more often progresses to SLE than the localised form.

  • see cutaneous lupus erythematosus.

  1. McCuistion CH. POSSIBLE DISCOID LUPUS ERYTHEMATOSUS IN NEWBORN INFANT. AMA Archives of Dermatology and Syphilology 1954;70:782.
  2. Ueki H. Cutaneous Calcinosis in Localized Discoid Lupus Erythematosus. Arch Dermatol 1980;116:196.
  3. Bangert JL. Subacute Cutaneous Lupus Erythematosus and Discoid Lupus Erythematosus. Arch Dermatol 1984;120:332.
  4. Callen JP. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Journal of the American Academy of Dermatology 1985;12:278-88.
  5. Mayou SC, Wojnarowska F, Lovell CR, Asherson RA, Leigh IM. Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus-their clinical significance. Clin Exp Dermatol 1988;13:389-92.
  6. David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LA. Clinical, Histologic, and Immunofluorescent Distinctions Between Subacute Cutaneous Lupus Erythematosus and Discoid Lupus Erythematosus. Journal of Investigative Dermatology 1992;99:251-7.
  7. Stratigos AJ, Antoniou C, Stamathioudaki S, Avgerinou G, Tsega A, Katsambas AD. Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 2004;29:150-3.
  8. Usmani N, Goodfield M. Efalizumab in the Treatment of Discoid Lupus Erythematosus. Arch Dermatol 2007;143.
  9. Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009;10:365-81.
  10. Järvinen TM, Hellquist A, Koskenmies S, et al. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus. Experimental Dermatology 2010;19:123-31.
  11. Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol 2013;27:391-404.
  12. Kuhn, A. (2016). S1-Leitlinie: Kutaner Lupus Erythematodes. Awmf.org. Retrieved 30 May 2016, from http://www.awmf.org/leitlinien/detail/ll/013-060.html